Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Buys Protein Chip Maker Protometrix

NEW YORK, April 2 (GenomeWeb News) - Invitrogen has acquired protein microarray company Protometrix, the companies said today.


Invitrogen said it will offer Protometrix's first product, a yeast proteome chip, this summer. Protometrix started selling its Yeast ProtoArray chip last fall.


In addition, Invitrogen plans to introduce protein microarrays for analyzing human kinase interactions and activity in the second half of the year. Furthermore, the company intends to develop arrays for diagnostics, biomarkers and biodefense research, and testing drug interactions and side effects. Invitrogen hopes the acquisition will add $3-5 million to its revenues this year.


Protometrix, based in Branford, Conn., was founded in 2001 based on technology developed by Michael Snyder at Yale University.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.